The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients–Insights from Rodent-Based Animal Studies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients–Insights from Rodent-Based Animal Studies
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 5, Pages 1122
Publisher
MDPI AG
Online
2019-03-06
DOI
10.3390/ijms20051122
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapies for Thoracic Aortic Aneurysms and Acute Aortic Dissections
- (2019) Dianna M. Milewicz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Decreased mitochondrial respiration in aneurysmal aortas of Fibulin-4 mutant mice is linked to PGC1A regulation
- (2018) I van der Pluijm et al. CARDIOVASCULAR RESEARCH
- Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials
- (2018) Federica Fogacci et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm
- (2018) Francesc Jiménez-Altayó et al. FREE RADICAL BIOLOGY AND MEDICINE
- A heart for fibrillin: spatial arrangement in adult wild-type murine myocardial tissue
- (2018) Felke Steijns et al. HISTOCHEMISTRY AND CELL BIOLOGY
- VESS07. Metformin Prescription Status and Abdominal Aortic Aneurysm Disease Progression in the U.S. Veteran Patient Population
- (2018) Nathan K. Itoga et al. JOURNAL OF VASCULAR SURGERY
- Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome
- (2018) Gisela Teixido-Tura et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
- (2018) Oscar Lomelí et al. Frontiers in Physiology
- Comparison of biomechanical properties in ascending aortic aneurysms of patients with congenital bicuspid aortic valve and Marfan syndrome
- (2018) Junfeng Yan et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Resveratrol reduces intracellular reactive oxygen species levels by inducing autophagy through the AMPK-mTOR pathway
- (2018) Jun Song et al. Frontiers of Medicine
- Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm
- (2017) Christine Gibson et al. JOURNAL OF APPLIED PHYSIOLOGY
- Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome
- (2017) Shaynah Wanga et al. JOURNAL OF PATHOLOGY
- AMPK: Mechanisms of Cellular Energy Sensing and Restoration of Metabolic Balance
- (2017) Daniel Garcia et al. MOLECULAR CELL
- Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome
- (2017) Jorge Oller et al. NATURE MEDICINE
- Cardiovascular Benefits of Moderate Exercise Training in Marfan Syndrome: Insights From an Animal Model
- (2017) Aleksandra Mas‐Stachurska et al. Journal of the American Heart Association
- Premature aortic smooth muscle cell differentiation contributes to matrix dysregulation in Marfan Syndrome
- (2017) Matthew Dale et al. PLoS One
- Cardiac remodeling in the mouse model of Marfan syndrome develops into two distinctive phenotypes
- (2016) Hyun-Jin Tae et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+Marfan Mouse ModelHighlights
- (2016) Stijntje Hibender et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and DissectionsHighlights
- (2016) Dianna M. Milewicz et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of exercise training and resveratrol on vascular health in aging
- (2016) Lasse Gliemann et al. FREE RADICAL BIOLOGY AND MEDICINE
- Resveratrol-induced autophagy promotes survival and attenuates doxorubicin-induced cardiotoxicity
- (2016) Jun Gu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Beneficial action of resveratrol: How and why?
- (2016) Gustavo Tomas Diaz-Gerevini et al. NUTRITION
- Participation of oleic acid in the formation of the aortic aneurysm in Marfan syndrome patients
- (2016) María Elena Soto et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Resveratrol and Cardiovascular Diseases
- (2016) Dominique Bonnefont-Rousselot Nutrients
- Doxycycline for Stabilization of Abdominal Aortic Aneurysms
- (2016) C. Arnoud Meijer et al. ANNALS OF INTERNAL MEDICINE
- Therapeutic potential of resveratrol in heart failure
- (2015) Miranda M. Sung et al. Annals of the New York Academy of Sciences
- Local MicroRNA Modulation Using a Novel Anti-miR-21–Eluting Stent Effectively Prevents Experimental In-Stent RestenosisSignificance
- (2015) Dong Wang et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Vascular Smooth Muscle Cell Phenotypic Changes in Patients With Marfan SyndromeSignificance
- (2015) Eva Crosas-Molist et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
- (2015) Yang Ruan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?
- (2015) Nimrat Grewal et al. HEART AND VESSELS
- Resveratrol protects against doxorubicin-induced cardiotoxicity in aged hearts through the SIRT1-USP7 axis
- (2015) Thomas K. Sin et al. JOURNAL OF PHYSIOLOGY-LONDON
- The Risk for Type B Aortic Dissection in Marfan Syndrome
- (2015) Alexander W. den Hartog et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intrinsic cardiomyopathy in Marfan syndrome: results from in-vivo and ex-vivo studies of the Fbn1 C1039G/+ model and longitudinal findings in humans
- (2015) Laurence Campens et al. PEDIATRIC RESEARCH
- Tetracyclines Disturb Mitochondrial Function across Eukaryotic Models: A Call for Caution in Biomedical Research
- (2015) Norman Moullan et al. Cell Reports
- A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome
- (2015) Jefferson J Doyle et al. eLife
- Aortopathy in Marfan syndrome: an update
- (2014) Federico Romaniello et al. CARDIOVASCULAR PATHOLOGY
- Role of miR-195 in Aortic Aneurysmal Disease
- (2014) Anna Zampetaki et al. CIRCULATION RESEARCH
- Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome
- (2014) Jason R. Cook et al. JOURNAL OF CLINICAL INVESTIGATION
- Analysis of Oxidative Stress Enzymes and Structural and Functional Proteins on Human Aortic Tissue from Different Aortopathies
- (2014) María Elena Soto et al. Oxidative Medicine and Cellular Longevity
- No Beneficial Effect of General and Specific Anti-Inflammatory Therapies on Aortic Dilatation in Marfan Mice
- (2014) Romy Franken et al. PLoS One
- Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway
- (2013) Ming-liang Chen et al. Autophagy
- SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: Implications for vascular aging
- (2013) María José Zarzuelo et al. BIOCHEMICAL PHARMACOLOGY
- Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
- (2013) Vernon W. Dolinsky et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Resveratrol Protects HUVECs from Oxidized-LDL Induced Oxidative Damage by Autophagy Upregulation via the AMPK/SIRT1 Pathway
- (2013) Hualei Guo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
- (2013) M. Groenink et al. EUROPEAN HEART JOURNAL
- Mechanosensitive microRNAs—role in endothelial responses to shear stress and redox state
- (2013) Traci Marin et al. FREE RADICAL BIOLOGY AND MEDICINE
- Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome
- (2013) Jan J.J. Aalberts et al. GENE
- Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome
- (2013) Munenori Takata et al. HEART AND VESSELS
- Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome
- (2013) Romy Franken et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Resveratrol Attenuates Doxorubicin-Induced Cardiomyocyte Apoptosis in Lymphoma Nude Mice by Heme Oxygenase-1 Induction
- (2012) Jun Gu et al. Cardiovascular Toxicology
- MMP-2 Regulates Erk1/2 Phosphorylation and Aortic Dilatation in Marfan Syndrome
- (2012) Wanfen Xiong et al. CIRCULATION RESEARCH
- Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome
- (2012) Alexander W Hartog et al. EXPERT OPINION ON PHARMACOTHERAPY
- Inflammation Aggravates Disease Severity in Marfan Syndrome Patients
- (2012) Teodora Radonic et al. PLoS One
- MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion
- (2012) L. Maegdefessel et al. Science Translational Medicine
- Elastin in Large Artery Stiffness and Hypertension
- (2012) Jessica E. Wagenseil et al. Journal of Cardiovascular Translational Research
- Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization
- (2011) Hidehiro Kaneko et al. ATHEROSCLEROSIS
- Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53
- (2011) C. Zhang et al. CARDIOVASCULAR RESEARCH
- Modulation of Anthracycline-Induced Cardiotoxicity by Aerobic Exercise in Breast Cancer
- (2011) Jessica M. Scott et al. CIRCULATION
- MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation
- (2011) Reinier A. Boon et al. CIRCULATION RESEARCH
- miR-29b Participates in Early Aneurysm Development in Marfan Syndrome
- (2011) Denis R. Merk et al. CIRCULATION RESEARCH
- Resveratrol Counteracts Systemic and Local Inflammation Involved in Early Abdominal Aortic Aneurysm Development
- (2011) Daniela Palmieri et al. JOURNAL OF SURGICAL RESEARCH
- Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography
- (2011) Nosheen Fatima et al. NUCLEAR MEDICINE COMMUNICATIONS
- Noncanonical TGF Signaling Contributes to Aortic Aneurysm Progression in Marfan Syndrome Mice
- (2011) T. M. Holm et al. SCIENCE
- MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity
- (2010) Martina Weber et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cardiovascular manifestations in men and women carrying a FBN1 mutation
- (2010) Delphine Détaint et al. EUROPEAN HEART JOURNAL
- The revised Ghent nosology for the Marfan syndrome
- (2010) B. L. Loeys et al. JOURNAL OF MEDICAL GENETICS
- Activation of SIRT1 by resveratrol induces KLF2 expression conferring an endothelial vasoprotective phenotype
- (2009) J. Gracia-Sancho et al. CARDIOVASCULAR RESEARCH
- Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome
- (2009) J. H. N. Lindeman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress
- (2009) H.H. Clarice Yang et al. VASCULAR PHARMACOLOGY
- Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome
- (2007) A W Y Chung et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started